ABT
Abbott Laboratories
Medical Devices · Healthcare · United States
111.27
close · 2026-08-13
value
76
cheaper than peers76
quality
68
stronger fundamentals68
ranked against
Medical Devices
value
quality
55 peerswide variation
Value inputs
| measure | company | vs peers |
| earnings yield, 1 year ago | 6.9% | 85 |
| earnings yield, 2 years ago | 2.9% | 85 |
| cash flow yield, 3 years ago | 4.1% | 85 |
| earnings yield, 3 years ago | 3.5% | 75 |
| cash flow yield, 1 year ago | 3.3% | 75 |
| cash flow yield, 2 years ago | 2.6% | 75 |
| earnings yield, latest year | 3.3% | 75 |
| forward P/E | 18.35× | 61 |
| cash flow yield, latest year | 3.8% | 55 |
| price to book | 3.77× | 48 |
| EV to EBITDA | 17.44× | 47 |
11 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 14.2% | 75 |
| revenue growth | 13.0% | 55 |
| debt to equity | 64.8% | 46 |
3 of 4 measures available
Facts
| market cap | $193B |
| free cash flow | — |
| employees | 122,000 |
| first trade | 1980-03-17 |
| next earnings | 2026-07-16 |
| fundamentals updated | 2026-07-26 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | 3.72 | 7.64 | 3.26 | 3.91 |
| free cash flow | $7.39B | $6.35B | $5.06B | $7.80B |
| net income | $6.52B | $13.40B | $5.72B | $6.93B |
| revenue | $44.33B | $41.95B | $40.11B | $43.65B |
| unusual items | $50.0M | $27.0M | -$41.0M | -$2.0M |